Safdar A*, Rodriguez GH, Rueda-Jaimes AM, Wierda WG, Ferrajoli A, O’Brien S, Koller CA, Musher DM, Bodey GP, Keating MJ. Immunogenicity and safety of multi-dose granulocyte macrophage-colony stimulating factor immune enhancement in patients with chronic lymphocytic leukemia receiving 23-valent polysaccharide pneumococcal vaccine: a prospective, randomized, controlled trial. Abstract # M-1006. The 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. September 17